Labetalol Does Not Lengthen Asystole During Electroconvulsive Therapy

SUMMARYLabetalol, a combined α- and β-adrenergic blocker is often used to attenuate the transient increases in heart rate and blood pressure that accompany electroconvulsive therapy (ECT). It has been suggested that labetalol should not be administered during ECT without the protection provided by a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of ECT 1998-12, Vol.14 (4), p.245-250
Hauptverfasser:	Dannon, Pinhas N, Iancu, Iulian, Hirschmann, Shmuel, Ross, Peter, Dolberg, Ornah T, Grunhaus, Leon
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic alpha-Agonists - adverse effects Adrenergic alpha-Agonists - therapeutic use Adrenergic beta-Agonists - adverse effects Adrenergic beta-Agonists - therapeutic use Adult Aged Biological and medical sciences Blood Pressure - drug effects Bradycardia - chemically induced Combined Modality Therapy Electroconvulsive Therapy Female Heart Arrest - chemically induced Heart Rate - drug effects Humans Labetalol - adverse effects Labetalol - therapeutic use Male Medical sciences Middle Aged Mood Disorders - therapy Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Schizophrenia - therapy Treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!